Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $104.21 billion. The enterprise value is $122.98 billion.
Important Dates
The last earnings date was Wednesday, May 21, 2025, before market open.
| Earnings Date | May 21, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Medtronic has 1.28 billion shares outstanding. The number of shares has decreased by -3.03% in one year.
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | -3.03% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 86.65% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 22.50 and the forward PE ratio is 14.64. Medtronic's PEG ratio is 2.72.
| PE Ratio | 22.50 |
| Forward PE | 14.64 |
| PS Ratio | 3.09 |
| Forward PS | 2.93 |
| PB Ratio | 2.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 19.95 |
| P/OCF Ratio | 14.68 |
| PEG Ratio | 2.72 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 12.86, with an EV/FCF ratio of 23.72.
| EV / Earnings | 26.38 |
| EV / Sales | 3.67 |
| EV / EBITDA | 12.86 |
| EV / EBIT | 18.36 |
| EV / FCF | 23.72 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.59.
| Current Ratio | 1.85 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | 2.98 |
| Debt / FCF | 5.50 |
| Interest Coverage | 9.19 |
Financial Efficiency
Return on equity (ROE) is 9.51% and return on invested capital (ROIC) is 5.46%.
| Return on Equity (ROE) | 9.51% |
| Return on Assets (ROA) | 4.61% |
| Return on Invested Capital (ROIC) | 5.46% |
| Return on Capital Employed (ROCE) | 8.50% |
| Revenue Per Employee | $353,021 |
| Profits Per Employee | $49,074 |
| Employee Count | 95,000 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.16 |
Taxes
In the past 12 months, Medtronic has paid $936.00 million in taxes.
| Income Tax | 936.00M |
| Effective Tax Rate | 16.63% |
Stock Price Statistics
The stock price has decreased by -1.63% in the last 52 weeks. The beta is 0.83, so Medtronic's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -1.63% |
| 50-Day Moving Average | 85.43 |
| 200-Day Moving Average | 87.19 |
| Relative Strength Index (RSI) | 37.92 |
| Average Volume (20 Days) | 7,389,938 |
Short Selling Information
The latest short interest is 12.24 million, so 0.95% of the outstanding shares have been sold short.
| Short Interest | 12.24M |
| Short Previous Month | 10.84M |
| Short % of Shares Out | 0.95% |
| Short % of Float | 0.96% |
| Short Ratio (days to cover) | 1.67 |
Income Statement
In the last 12 months, Medtronic had revenue of $33.54 billion and earned $4.66 billion in profits. Earnings per share was $3.61.
| Revenue | 33.54B |
| Gross Profit | 21.97B |
| Operating Income | 6.70B |
| Pretax Income | 4.81B |
| Net Income | 4.66B |
| EBITDA | 9.56B |
| EBIT | 6.70B |
| Earnings Per Share (EPS) | $3.61 |
Full Income StatementBalance Sheet
The company has $8.97 billion in cash and $28.52 billion in debt, giving a net cash position of -$19.55 billion or -$15.25 per share.
| Cash & Cash Equivalents | 8.97B |
| Total Debt | 28.52B |
| Net Cash | -19.55B |
| Net Cash Per Share | -$15.25 |
| Equity (Book Value) | 48.26B |
| Book Value Per Share | 37.46 |
| Working Capital | 10.94B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $7.04 billion and capital expenditures -$1.86 billion, giving a free cash flow of $5.19 billion.
| Operating Cash Flow | 7.04B |
| Capital Expenditures | -1.86B |
| Free Cash Flow | 5.19B |
| FCF Per Share | $4.04 |
Full Cash Flow StatementMargins
Gross margin is 65.51%, with operating and profit margins of 19.97% and 13.90%.
| Gross Margin | 65.51% |
| Operating Margin | 19.97% |
| Pretax Margin | 16.78% |
| Profit Margin | 13.90% |
| EBITDA Margin | 28.51% |
| EBIT Margin | 19.97% |
| FCF Margin | 15.46% |
Dividends & Yields
This stock pays an annual dividend of $2.80, which amounts to a dividend yield of 3.45%.
| Dividend Per Share | $2.80 |
| Dividend Yield | 3.45% |
| Dividend Growth (YoY) | 1.45% |
| Years of Dividend Growth | 49 |
| Payout Ratio | 77.56% |
| Buyback Yield | 3.03% |
| Shareholder Yield | 6.50% |
| Earnings Yield | 4.51% |
| FCF Yield | 5.01% |
Dividend DetailsAnalyst Forecast
The average price target for Medtronic is $94.73, which is 16.53% higher than the current price. The consensus rating is "Hold".
| Price Target | $94.73 |
| Price Target Difference | 16.53% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 5.21% |
| EPS Growth Forecast (5Y) | 17.13% |
Stock ForecastsStock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |